## Analysis of Alkylating Agents ### Correct Statements **Option 1: Cyclophosphamide Activation** - Cyclophosphamide is a **prodrug** that undergoes hepatic metabolism via cytochrome P450 (primarily CYP2C9 and CYP3A4) - Converted to active metabolites including phosphoramide mustard and acrolein - [cite:KD Tripathi Ch 65] **Option 2: Nitrogen Mustards and DNA Cross-linking** - Nitrogen mustards (mechlorethamine, cyclophosphamide, ifosfamide) form **inter-strand DNA cross-links** - Covalent bonding between guanine residues on opposite DNA strands prevents replication and transcription - This is the primary mechanism of cell death **Option 4: Nitrosoureas and CNS Penetration** - Nitrosoureas (carmustine, lomustine) are **highly lipophilic** - Readily cross the blood-brain barrier due to their lipophilicity - Used for brain tumors and CNS lymphomas - [cite:Harrison 21e Ch 96] ### Incorrect Statement (The Answer) **Option 3: Busulfan and Myelosuppression** - Busulfan is an alkylating agent used in CML and as a conditioning agent for bone marrow transplantation - However, busulfan causes **SEVERE myelosuppression** — not minimal - Dose-limiting toxicity is bone marrow suppression - Also causes pulmonary fibrosis ("busulfan lung") and hepatic veno-occlusive disease (VOD) - [cite:KD Tripathi Ch 65] **Key Point:** Busulfan is notorious for **profound myelosuppression** and requires careful monitoring of blood counts. It is NOT sparing of the bone marrow. **High-Yield:** Alkylating agents share a common mechanism: formation of DNA cross-links. However, their toxicity profiles differ — busulfan's major toxicity is myelosuppression, while cyclophosphamide's is hemorrhagic cystitis (acrolein metabolite) and mesna is used as a uroprotective agent. **Clinical Pearl:** When busulfan is used in high doses for stem cell transplantation conditioning, it requires close monitoring and supportive care due to the risk of hepatic VOD, which can be life-threatening.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.